Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Arko Corp. (ARKO) vs Cronos Group Inc (CRON) Price & Performance

Arko Corp.Trade
Cronos Group IncTrade

Price performance (Past 24H)

Key statistics

Arko Corp. vs Cronos Group Inc — how do they compare? Arko Corp. trades at $4.46 (market cap $527.27M), while Cronos Group Inc trades at $3.08 (market cap $1.11B). The key difference: Cronos Group Inc is far larger — about 2.1× Arko Corp.'s market cap, and Arko Corp. pays a 2.55% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.

ARKOCRON
Market Cap
$527.27M$1.11B
Sector
Consumer CyclicalHealth
52-Week High
$8.64$3.27
52-Week Low
$3.82$2.30
Enterprise Value
$2.71B$310.67M
Dividend Yield
2.55%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Arko Corp.

ARKO Corp. (NASDAQ: ARKO) trades at $5.66, down 22.36% following weak Q2 2026 earnings that missed expectations. The stock shows bearish technical signals with oversold RSI readings near support at $5. Despite revenue declining to $7.64B in 2025, the company maintains positive cash flow and recently paid a $0.03 dividend. Analyst consensus remains cautious with 100% hold ratings amid concerns about consumer spending pressures.

The outlook remains challenging with declining revenues and thin profit margins (0.38% net margin), though management maintains 2026 EBITDA guidance. Key risks include competitive pressure in convenience retail and sensitivity to fuel price volatility. The current valuation at 0.08 P/S ratio may attract value investors if operational improvements materialize.

Cronos Group Inc

CRON trades at $3.10 with a 0.98% daily gain, showing bullish technical momentum. The company delivered strong Q2 2026 results with 58% YoY revenue growth and earnings beat, while maintaining #1 market share in Canadian vapes and edibles. Despite negative net income in 2025, revenue growth accelerated to $147M with improving margins. Technical indicators show bullish moving averages but RSI suggests potential overbought conditions near $3 resistance.

Outlook remains positive with international expansion and European cannabis legalization driving growth, though competitive pressures and execution risks persist. Analyst consensus is mixed with 60% hold ratings, reflecting cautious optimism about CRON's turnaround trajectory from previous losses to projected 39% profit margin by 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Arko Corp.

ARKO Corp operates as a holding company. The company, through its subsidiaries, owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in three segments: Retail, Wholesale, and GPM Petroleum. The company derives the majority of its revenue from retail and wholesale distribution of fuel.

Read more on ARKO

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON